IGC Pharma, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IGC Pharma, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • IGC Pharma, Inc. Depreciation for the quarter ending September 30, 2024 was $145K, a 3.57% increase year-over-year.
  • IGC Pharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $573K, a 48.4% increase year-over-year.
  • IGC Pharma, Inc. annual Depreciation for 2023 was $563K, a 35% increase from 2022.
  • IGC Pharma, Inc. annual Depreciation for 2022 was $417K, a 33.5% decline from 2021.
  • IGC Pharma, Inc. annual Depreciation for 2021 was $627K, a 35.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $563K +$146K +35% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $417K -$210K -33.5% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $627K +$165K +35.7% Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $462K +$328K +245% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $134K +$75K +127% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $59K Apr 1, 2018 Mar 31, 2019 10-K 2020-07-13
2013 $712K +$38.4K +5.7% Apr 1, 2013 Mar 31, 2014 10-K 2014-07-15
2012 $674K -$322K -32.4% Apr 1, 2012 Mar 31, 2013 10-K 2014-07-15
2011 $996K Apr 1, 2011 Mar 31, 2012 10-K/A 2014-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.